WWW.EXFILE.COM, INC. -- 888-775-4789 -- BOSTON SCIENTIFIC CORP. -- FORM 8-K
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
__________________________
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
__________________________
Date of
Report (Date of earliest event reported): October 21, 2008
BOSTON SCIENTIFIC
CORPORATION
(Exact
name of registrant as specified in charter)
|
DELAWARE
|
1-11083
|
04-2695240
|
|
(State or other
jurisdiction of incorporation)
|
(Commission file
number)
|
(IRS employer identification
no.)
|
One Boston Scientific Place,
Natick, Massachusetts 01760-1537
(Address
of principal executive offices)(Zip code)
Registrant’s
telephone number, including area code: (508) 650-8000
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the fling obligation of the registrant under any of the following
provisions:
[
] Written communication pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
[
] Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
[
] Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
[
] Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
ITEM
2.02. RESULTS OF OPERATIONS AND FINANCIAL
CONDITION.
On
October 21, 2008, Boston Scientific Corporation (the “Company”) issued a press
release announcing financial results for the third quarter ended September 30,
2008. A copy of the release is furnished with this report as Exhibit
99.1.
The
information in this Current Report on Form 8-K and the Exhibit attached hereto
shall not be deemed “filed” for purposes of Section 18 of the Securities
Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the
liabilities of that section, nor shall it be deemed incorporated by reference in
any filing under the Securities Act of 1933 or the Exchange Act, regardless of
any general incorporation language in such filing.
ITEM
9.01. FINANCIAL STATEMENTS AND EXHIBITS.
| Exhibit |
|
| Number |
Description |
| |
|
| 99.1 |
Press Release issued
by Boston Scientific Corporation dated October 21,
2008. |
SIGNATURE
Pursuant to the
requirements of the Securities and Exchange Act of 1934, as amended, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
| |
BOSTON
SCIENTIFIC CORPORATION |
|
| |
|
|
|
|
Date:
October 21, 2008
|
By:
|
/s/ Lawrence
J. Knopf |
|
| |
|
Lawrence
J. Knopf |
|
| |
|
Senior
Vice President and Deputy General Counsel |
|
| |
|
|
|
INDEX
TO EXHIBITS
| Exhibit |
|
| Number |
Description |
| |
|
| 99.1 |
Press Release issued
by Boston Scientific Corporation dated October 21,
2008. |